$2.9M research grant funds technology for MS stem cell therapy

Multiple Sclerosis News Today reported that a UB study, co-led by Stelios Andreadis, has been awarded $2.9 million to study stem cell therapies for multiple sclerosis (MS).  

“The work we plan to undertake has significant implications for regenerative medicine, as it has the potential to develop novel strategies to enhance stem cell delivery for treatment of devastating neurological diseases that remain intractable to current treatments,” said Andreadis.